Published in Breast Cancer Res Treat on September 18, 2013
Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study. Clin Genitourin Cancer (2015) 0.81
Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies. Breast Cancer Res Treat (2015) 0.81
Association between global biomarkers of oxidative stress and hip fracture in postmenopausal women: a prospective study. J Bone Miner Res (2014) 0.76
Phobic Anxiety and Plasma Levels of Global Oxidative Stress in Women. Eur J Psychiatry (2015) 0.75
Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II. Breast Cancer Res Treat (2016) 0.75
Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study. BMC Urol (2015) 0.75
Effects of physical activity on systemic oxidative/DNA status in breast cancer survivors. Oncol Lett (2016) 0.75
Healthy Dietary Patterns and Oxidative Stress as Measured by Fluorescent Oxidation Products in Nurses' Health Study. Nutrients (2016) 0.75
Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol (2006) 21.58
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Oxidative stress: oxidants and antioxidants. Exp Physiol (1997) 6.12
The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol (2004) 5.14
Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Oxidative stress and cancer: have we moved forward? Biochem J (2007) 4.20
Epidemiology of breast cancer. Lancet Oncol (2001) 3.58
Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem (2004) 3.54
Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol (2008) 3.41
The nurses' health study. Am J Nurs (1978) 3.00
Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res (2011) 2.54
Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr (2000) 2.46
Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr (2012) 2.25
Role of oxygen free radicals in cancer development. Eur J Cancer (1996) 2.20
Radiation and breast cancer: a review of current evidence. Breast Cancer Res (2004) 2.12
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07
F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal (2008) 1.99
Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies. Am J Epidemiol (2007) 1.68
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem (1994) 1.53
Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat (2000) 1.51
Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 1.48
Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology (2003) 1.47
Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. Am J Clin Nutr (2002) 1.37
Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study. J Clin Oncol (2009) 1.31
Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst (2012) 1.31
Oxidant damage of the lipids and proteins of the erythrocyte membranes in unstable hemoglobin disease. Evidence for the role of lipid peroxidation. J Clin Invest (1983) 1.21
Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem (1999) 1.21
Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther (2001) 1.21
DNA damage, DNA repair, and alcohol toxicity--a review. Alcohol Clin Exp Res (1997) 1.19
Oxidative stress in breast cancer. Med Oncol (2005) 1.17
Stability of measurements of biomarkers of oxidative stress in blood over 36 hours. Cancer Epidemiol Biomarkers Prev (2004) 1.14
The reaction of DNA with lipid oxidation products, metals and reducing agents. Biochim Biophys Acta (1984) 1.12
Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct (2007) 1.08
Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men. Am J Epidemiol (2007) 1.06
Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct (2002) 1.04
Increased levels of transition metals in breast cancer tissue. Neuro Endocrinol Lett (2006) 1.03
Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic Res (2004) 0.99
Fluorescent oxidation products and risk of coronary heart disease: a prospective study in women. J Am Heart Assoc (2013) 0.94
Fluorescence formation from the interaction of DNA with lipid oxidation degradation products. Biochim Biophys Acta (1987) 0.87
Metals and breast cancer. J Mammary Gland Biol Neoplasia (2013) 0.87
Breast cancer and urinary biomarkers of polycyclic aromatic hydrocarbon and oxidative stress in the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev (2010) 0.86
Plasma malondialdehyde and obesity: is there a relationship? Clin Chem Lab Med (2000) 0.82
Daily variations of plasma malondialdehyde levels in patients with early breast cancer. Cancer Detect Prev (2003) 0.81
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst (2004) 3.28
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum (2009) 2.19
Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol (2006) 2.14
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14
Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 2.09
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07
Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab (2007) 2.07
Teenage acne and cancer risk in US women: A prospective cohort study. Cancer (2015) 2.05
Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med (2008) 2.01
Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause (2004) 1.97
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95
Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev (2007) 1.95
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer (2007) 1.76
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res (2006) 1.68
Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res (2004) 1.67
Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol (2009) 1.62
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59
Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts. Br J Nutr (2012) 1.59
Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev (2006) 1.57
Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol (2010) 1.56
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47
Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer (2007) 1.43
Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin Chem (2013) 1.37
Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res (2005) 1.37
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation (2013) 1.33
ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer (2010) 1.33
Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells. Cancer Res (2012) 1.30
Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 1.30
Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Prev Med (2004) 1.29
Breastfeeding and risk of ovarian cancer in two prospective cohorts. Cancer Causes Control (2007) 1.27
Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2005) 1.26
A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res (2013) 1.25
Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol (2007) 1.25
Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.22
Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2010) 1.20
Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.16
Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer (2009) 1.16
Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Cancer Epidemiol Biomarkers Prev (2013) 1.12
Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int J Cancer (2009) 1.11
Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer (2007) 1.11
Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol (2012) 1.09
No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2005) 1.09
Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst (2011) 1.09
Within-person reproducibility of urinary bisphenol A and phthalate metabolites over a 1 to 3 year period among women in the Nurses' Health Studies: a prospective cohort study. Environ Health (2013) 1.09
Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Breast Cancer Res (2013) 1.08
Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis. J Ovarian Res (2012) 1.07
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res (2004) 1.05
Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts. Am J Epidemiol (2009) 1.05
The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev (2006) 1.04
Association of urinary concentrations of bisphenol A and phthalate metabolites with risk of type 2 diabetes: a prospective investigation in the Nurses' Health Study (NHS) and NHSII cohorts. Environ Health Perspect (2014) 1.04
Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer (2010) 1.03
Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst (2012) 1.02
Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.02
Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast Cancer Res (2010) 1.02
A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer. Am J Epidemiol (2013) 1.01
Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones. Cancer Causes Control (2007) 1.01
Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women. Am J Clin Nutr (2013) 1.00
Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk. Cancer Epidemiol Biomarkers Prev (2012) 1.00
Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol (2011) 1.00
Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res (Phila) (2011) 1.00
The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies. Cancer Causes Control (2007) 1.00
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99
Human plasma ghrelin levels increase during a one-year exercise program. J Clin Endocrinol Metab (2004) 0.98
A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemiol Biomarkers Prev (2011) 0.96
Adult weight change and incidence of premenopausal breast cancer. Int J Cancer (2011) 0.96
Relationship between epidemiologic risk factors and hormone receptor expression in ovarian cancer: results from the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev (2009) 0.96
Adolescent physical activity in relation to breast cancer risk. Breast Cancer Res Treat (2014) 0.95
The association of plasma fluorescent oxidation products and chronic kidney disease: a case-control study. Am J Nephrol (2012) 0.94
Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control (2015) 0.94
Fluorescent oxidation products and risk of coronary heart disease: a prospective study in women. J Am Heart Assoc (2013) 0.94
Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses' health study. Obesity (Silver Spring) (2009) 0.94
β-Carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent. Am J Clin Nutr (2012) 0.93
Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev (2012) 0.92
Validation of tissue microarray technology in ovarian cancer: results from the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev (2008) 0.92
Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2010) 0.92
Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors. Breast Cancer Res Treat (2006) 0.91
Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations. Int J Cancer (2009) 0.91
Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev (2012) 0.91
MTHFR polymorphisms in relation to ovarian cancer risk. Gynecol Oncol (2010) 0.90
Premenopausal dietary fat in relation to pre- and post-menopausal breast cancer. Breast Cancer Res Treat (2014) 0.90
Adolescent meat intake and breast cancer risk. Int J Cancer (2014) 0.90
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst (2015) 0.90
ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control (2012) 0.90